The closing of the business combination with PowerUp Acquisition Corp. creates Nasdaq-listed biopharmaceutical company ...

Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that it will effect a 1-for-5 ...

Aspire Biopharma (ASBP) and PowerUp Acquisition (PWUP) announced the completion of their previously announced business combination. Proceeds ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.

Pfizer (PFE) discontinues Beqvez hemophilia B therapy developed with Roche (RHHBY) due to low demand, shifting focus to an ...

As of February 17, 2025, 1,028 unique patient prescriptions for Attruby have been written by 516 unique prescribers since FDA approval - Attruby (acoramidis), the first and only near-complete TTR ...

Thursday marks 22 years since 100 people died and more than 200 others were injured in a fire at the Station nightclub in ...

The Allspring Emerging Growth Fund underperformed the Russell 2000 Growth Index during the quarter that ended December 31, ...

Company achieved significant commercial progress in 2024, finishing with total revenue of $333.6 million, including $319.2 million in U.S. Net Product Sales Company reaffirms combined peak sales of IB ...

YORVIPATH is a first-in-class PTH replacement therapy. A prodrug of parathyroid hormone (PTH [1-34]), YORVIPATH is administered subcutaneously once daily, with sustained release of active PTH designed ...

Here's how voters rated President Biden's performance. Here's how voters rated President Trump's performance. Here's how voters rated President Obama's performance.